Key facts
- It has raised $11.6M across 1 recorded rounds; the latest was Early Stage VC ($11.5M) in Jul 2024.
- Notable investors include Wisconsin Investment Management Company, Santé Ventures, Venture Investors Health Fund.
- Ten Bay Bio has filed 2 Form Ds with the SEC since 2024, most recently May 2025 ($11.5M sold to 6 investors).
- Status: Privately Held (backing).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Ten Bay Bio
Create free account
No card required
Funding rounds
1 roundsAbout Ten Bay Bio
Provider of biological therapies intended to address complex diseases in immunology. The company is currently operating in stealth mode.
- Sector
- Healthcare
- HQ
- Milwaukee, WI, United States
- Founded
- 2024
- Ownership
- Privately Held (backing)
PA Mark — not yet priced
Ten Bay Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Ten Bay Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Ten Bay Bio in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.